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Audiologic Features of Norrie Disease 
Chris Halpin, PhD; Grace Owen, ScD; Gustavo A. Guti&rez-Espeleta, PhD; 
Katherine Sims, MD; Heidi L. Rehm, PhD 
Objectives: Norrie disease is an X-linked recessive disorder in which patients are born blind and develop sensory hearing 
loss in adolescence. The hearing loss associated with Norrie disease has been shown in a genetically altered knockout 
mouse to involve dysfunction of the stria vascularis; most other structures are preserved until the later stages of the 
disease. The objective of this study was to characterize the audiologic phenotype of Nark disease for comparison with 
the pathophysiologic mechanism. 
Methods: The design combined two series of clinical audiologic evaluations, with special attention to speech intelligi-
bility. 
Results: The audiologic results for 12 affected individuals and 10 carriers show that patients with Norrie disease retain 
high speech intelligibility scores even when the threshold loss is severe. 
Conclusions: The cochlear mechanism — failure of the stria vascularis — accounts for some of the higher values in the 
wide distribution of speech scores in cases with similar pure tone and iograms. 
Key Words: audiometry, NDP gene, Norrie disease, speech intelligibility, stria vascularis. 
INTRODUCAON 
Norrie disease is an X-linked recessive disorder 
caused by point mutations in the NDP gene at 
Xp11.4.1.2 Affected individuals are born blind, with 
pseudogliomas of the eyes, and exhibit various de-
grees of mental and emotional dysfunction. The au-
diologic features of Norrie disease were described 
previously by Parving and Warburg .3 These authors 
found normal hearing at birth, with the onset of hear-
ing loss in early adolescence and progression to an-
acucis late in life_ They also found good word recog-
nition scores (80% correct or better for monosylla-
bles). Further study by this same group indicated a 
cochlear site of lesion .4 Molecular genetic studies 
have identified the Norrie disease gene (NDP),1.2 char-
s terized the protein (norrin),5 and generated aknock-
out mouse.6 Rehm et al7 used light and confocal mi-
croscopy to identify the specific sites of cochlear dis-
ease in the mouse model of Norrie disease. These au-
thors showed gross developmental abnormalities of 
the stria vascularis in the knockout mice by 3 months 
of age compared with normal littermates. Most other 
structures in the cochlea appeared normal in affected 
mice at this age. Longitudinal analysis showed that 
the initial effects in the cochlea occur in the stria; 
neurons and hair cells are affected in the later stages 
of life. This article presents the audiologic results of 
two series of patients with Norrie disease. 
METHODS 
Two clinical investigations are presented. The first 
reflects a series of patients in the United States. Af-
ter informed consent procedures were completed, 6 
affected individuals (male), 2 carriers (mothers), and 
4 unaffected family members (2 fathers and 2 female 
siblings) were tested. Diagnosis of Norrie disease had 
previously been made in thcsc families and was con-
firmed by molecular analysis showing point muta-
tions in the NDP gene. Most patients were evaluated 
by standard audiometry for pure tones. 8 Speech intel-
ligibility was evaluated with 50-item CID W22 word 
lists on compact disc.9 One affected adult, institu-
tionalized for severe mental disability, was evalu-
ated by threshold auditory brain stern response audi-
ometry. One other affected adult, also severely men-
tally disabled, was evaluated behaviorally by a condi-
tioning procedure. (For an overview of audiologic 
methods in genetic investigations, see the 1995 arti-
cle by Halpin.1°) 
The second investigation took place in CostaRica. 
After giving informed consent, subjects were evalu- 
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Fig 1. Output of Harvard Audiometer 
Operating System software .1 3 Audiology 
case screen consists of standard pure 
tone audiogram (on right) and speech in-
telligibility space (on left). This space 
consists of speech signal intensity on 
horizontal axis from 0 to 110 dB hear-
ing level, and percent correct on verti-
cal axis. Clinical test results (CID W22) 
are plotted by level and score in this 
space such that horizontal tick on data 
point bars (red, right blue, left) repre-
sent score, and extent of bars represents 
95% critical difference from another 
score.14 Vertical axis is arc sine trans-
formed such diacritical difference bars 
will remain same size even though vari-
ance of speech scores changes, given 
range in which score is found. Ogive 
("5") curves represent performance 
function predicted by Articulation Index 
given right and left ear thresholds.13 
Similar ogive is calculated for condition 
with all thresholds at limit of normal 
hearing (20 dB hearing level) and forms 
outer boundary of normal range (shaded 
gray for reference). This Figure shows 
example cases from both A ,B) United 
States and C) Costa Rica. 
ated by a certified audiologist who was a native speak-
er of Spanish (0.0.). Medical and molecular diagno-
sis of Norrie disease had also been previously con-
firmed in this large family.11 Six affected male indi-
viduals, 8 female carriers, and 20 unaffected family 
members were tested. The subjects were evaluated by 
standard pure tone audiometry in a quiet, but not 
sound-treated, room. Objective intensity calibration 
was guaranteed by daily use of a sound level cali-
brator (BA-201-25, Quest Technologies, Oconomo-
woc, Wisconsin) that never showed variations within 
standard one-third-octave filter bands greater than 1  
dB sound pressure level. In situ biocalibration of the 
test room for the effect of noise resulted in audio-
grains of normal listeners with no thresholds higher 
than 20 dB hearing level. This level of test sensitiv-
ity is sufficient to reliably separate Norrie disease 
(or any other) effects from normal hearing subjects. 
An affected 2-year-old boy was evaluated by a con-
ditioning procedure appropriate for his age group. 
In CostaRica, speech intelligibility was evaluated 
in adults with 50-item Spanish bisyllable lists deliv-
ered by compact disc. The lists used were selected 
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Fig 2. Output of Harvard Audiometer 
Operating System software. 15 Unusual 
cases. A) Patient has near-normal speech 
ability with severe hearing loss. B) 
Least-affected individuaL C) Female ob-
ligate carrier (mother of patients in Figs 
1B and 2A) is only carrier with hearing 
Toss of 10 carriers evaluated. I 10 20 30 40 50 61 70 10 90 1001 
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because their published performance/intensity func-
tion 12 had a practically identical slope and intercept 
to that of the CID W22 lists used in the United States. 
The expected values and variability of these lists are 
equivalent, and they are plotted interchangeably with-
in the speech intelligibility space on the audiograms 
in Figs 11315 and 2.15 
RESULTS 
Figure 1 shows 3 cases that illustrate the general 
progression of the hearing loss. Figure IA reflects a 
14-year-old individual with an intragenic deletion in 
exon 2. (Mutation identifications were performed in  
the laboratory of author K. Sims.) His documented 
hearing was normal up to 7 years of age. This audio-
gram shows the high-frequency emphasis and asym-
metry often reported in the earlier stages. Speech in-
telligibility was also affected, but his scores did not 
fall below 78% correct. The sensory hearing loss in 
these two series (US and Costa Rica) progressed to a 
relatively stable state during the third and fourth de-
cades of life, with features illustrated by Fig 1B . In 
this 40-year-old individual (mutation R109X), the 
threshold loss had become severe (approximately 70 
dB hearing level), flat, and symmetric, with preserva-
tion of word recognition near 80% correct. Figure 
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Fig 3. Summary of clinical test results. A) Thresholds at 
2 kHz versus ago for each ear of each affected individuaL 
B) Word recognition scores (CID W22, and equivalent 
Spanish lists) for each ear by age. Exceptions to this are 
individuals evaluated by auditory brain stem responses 
and conditioning /tachometry, who are given single data 
point for threshold and none for speech intelligibility. 
1C shows the clinical results of the oldest individual 
(58 years of age, L61F). 11 In this case, the symmetry 
between ears seen in middle-aged individuals is break-
ing down. Although the right ear still exhibits the se-
vere flat hearing loss with speech discrimination at 
74%, the left ear shows a further threshold loss and 
an extreme decrease in speech intelligibility (18%). 
Figure 2 shows 3 cases that reflect some findings 
of individual interest. The results in Fig 2A (38 years 
of age, the brother of patient in Fig 1B; R109X) should 
be noted for unusual interpretation in light of speech 
score analysis using the Articulation Index .13 Al-
though the absolute scores (60% right and 52% left) 
could be considered poor, these scores are not signifi-
cantly different from the predicted values for the Ar-
ticulation Index calculation 14 (In Fig 2A, the vari-
ance bars touch the ogive curves.") This means that 
a normal listener would get a similar score with the 
same limited amount of audible speech. Therefore, 
this case, with its low score, does not detract from 
the general trend for very good speech intelligibility 
in the presence of severe cochlear disease. 
Figure 2B shows the individual with the least hear-
ing loss. At this age (44 years), he would be expected 
to exhibit a severe flat loss on both sides (as in Fig 
1B). Although his sensory loss resembles a "4-kHz 
notch," this patient had no history of any exposure 
to gunfire or industrial noise. Interestingly, this pa- 
tient has a mutation in the NDP gene (R121Q), which 
has been observed to be milder in terms of both the 
eye phenotypel6 and the lack of bearing loss reported 
in one family.'7  Further studies will be needed to in-
vestigate specific mutations that may be indicative 
of normal or near-normal hearing. 
Finally, Fig 2C depicts the data of the mother of 2 
affected individuals (Figs 1B and 2A), who is there-
fore an obligate carrier. This was the only 1 of the 10 
carriers in these two series who had a severe, sym-
metric sensorineural heating loss similar to that seen 
in Norrie disease. This is a very unusual and possi-
bly coincidental finding, as hearing loss in carriers 
has not been seen in previous reports.18,19 It is also 
possible that the hearing loss is a manifestation of 
nonrandom X-inactivation (or chance segregation of 
such cells) in the ear tissue. Such a case involving 
eye disease in a female NDP gene mutation carrier 
has been described.20 
A summary of the combined clinical test results 
for all affected individuals can be found in Fig 3. 
These results show complete penetrance of sensory 
hearing loss in all affected individuals 14 years of 
age and older. (One US individual, shown in Fig 2B, 
is affected at frequencies not graphed.) The graph 
includes threshold data from 2 mentally disabled in-
dividuals. One of these data points (at 41 years of 
age) was interpolated from a 65 dB normal hearing 
level auditory brain stem response to a broadband 
click including 2 kHz within its bandwidth, and an-
other (at 44 years of age) contributes a single 2-kHz 
threshold found in the sound field. The youngest in-
dividual (2 years of age) contributes a single 2-kHz 
value in the normal range, found with a condition-
ing procedure. None of these 3 individuals contribute 
to the speech data (Fig 3B). Although the progres-
sive loss shows a high-frequency emphasis and no-
table asymmetry in the earlier stages, the progression 
seems to result in a symmetric, bilateral, flat sensory 
loss for patients above 35 years of age. This loss 
seems generally stable for 2 to 3 decades by both 
these data and clinical history. The speech intelli-
gibility scores (Fig 3B) are fairly high (mean, 78%), 
given the severity of the hearing loss. These are also 
fairly stable up to 58 years of age. 
DISCUSSION 
The results of this investigation confirm and ex-
tend those reported by Parving and Warburg.3 In terms 
of threshold, the hearing losses are sensorineural, mild, 
asymmetric, and high-frequency in adolescence, and 
progress to a severe, symmetric, flat loss around 35 
years of age. The previous audiometric and medical 
reports include several individuals around 25 years 
0 
10 
20 
-J AO 
so 
'e 60 
70 
BO 
90 
537 	 Halpin et al, Audiologic Features of Norrie Disease 	 537 
of age and older than 50 years of age 321 'This study 
provides a number of audiograms in the intervening 
age range, and these results indicate that the disease 
does not progress steadily, but generally achieves a 
steady state of severe loss from about 35 years of age 
to nearly 60 years of age. There is some evidence 
from this study, that of Parving and Warburg,3 and 
the reported temporal bone from a 77-year-old indi-
vidual22 that suggests that a very severe degeneration 
follows at about 60 years of age. Whereas Warburg23  
initially estimated the penetrance of sensorineural 
hearing loss at 33%, several other reports showed 
loss in all tested individuals above the age of puber-
ty.3.21.24 In this study as well, all men over 13 years 
of age showed clear sensorineural loss, indicating 
100% penetrance of this feature. 
Norrie disease serves as a rare example in which 
audiologic speech intelligibility can be studied with-
in a group whose cochlear pathophysiology arises 
from the same mechanism, and that mechanism is 
indicated by a supporting mouse model. Speech in-
telligibility can be a more informative challenge to a 
dysfunctional cochlea than the binary detection task 
of the pure tone audiogram, and therefore can be more 
informative about the underlying state of the organ 
of Corti.25 Although the audiograms of cochleas with 
different pathophysiologic mechanisms may be quite 
similar,26 the differences in clinical speech scores are 
more likely to be informative regarding different un-
derlying disorders (and prognoses for hearing aids).27 
This is especially true if at least one such mecha-
nism allows for remarkably high scores, as is the case  
in Norrie disease. Clinicians routinely observe simi-
lar audiograms with much lower scores, and possi-
bly the different mechanisms in such cases may be 
further quantified as similar models become avail-
able. 
Some authors have suggested that all sensory hear-
ing loss is the result of outer hair cell loss plus inner 
hair cell loss.28 Although not specifically stated, such 
an approach would suggest that speech intelligibil-
ity would be predictable from threshold audiogram 
values alone and that the range actually seen in the 
clinic could be attributed to poor test reliability. The 
results of this study clearly do not support this asser-
tion, as they indicate the stria vascularis as at least 
one additional mechanism. With the clear possibil-
ity of complex interactions among the mechanisms 
resulting in both high and low scores, speech scores 
remain valuable in parsing individual cochlear dys-
function and should be measured and applied within 
clinical cases, rather than assumed to be predictable 
from pure tone threshold values. 
In a more general sense, it is important to remem-
ber that "sensory hearing loss" is a symptom of a va-
riety of cochlear dysfunctions and is not expected to 
give coherent results when different pathophysiologic 
mechanisms are grouped together. In this study, mo-
lecular genetics, pathophysiology, and speech audi-
ometly provide insight into a specific cochlear mech-
anism that limits patient performance. Similar collab-
orations in the future may allow separate study of other 
specific cochlear disorders. 
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